The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria
- PMID: 18186976
- DOI: 10.1179/136485908X252214
The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria
Abstract
Although artemisinin and its derivatives are widely used for the treatment of malaria, they also have antischistosomal activity. In a small study in eastern Sudan, the effects of the treatment of uncomplicated, Plasmodium falciparum malaria with artesunate-sulfamethoxypyrazine-pyrimethamine (AS-SMP) and artemether-lumefantrine (AT-LU) on co-infections with Schistosoma mansoni were therefore investigated. Faecal samples from 14 of the 306 patients screened on presentation, at the start of a clinical trial of antimalarial treatment, were found to contain Schistosoma mansoni eggs. For the treatment of their malaria, the 14 egg-positive cases, who were aged 6-40 years (mean = 13.7 years), were each subsequently treated with three tablets of a fixed combination of AS-SMP, with a 12-h (six patients) or 24-h interval (five patients) between each tablet, or with six doses of AT-LU given over 3 days. When checked 28 and 29 days after the initiation of treatment, all 14 patients were found stool-negative for schistosome eggs. These results indicate that AS-SMP and AT-LU are currently very effective treatments not only for uncomplicated, P. falciparum malaria but also for S. mansoni infections.
Similar articles
-
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.Am J Trop Med Hyg. 2006 Oct;75(4):630-6. Am J Trop Med Hyg. 2006. PMID: 17038684 Clinical Trial.
-
Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients.J Infect Dev Ctries. 2013 Jun 15;7(6):468-74. doi: 10.3855/jidc.2658. J Infect Dev Ctries. 2013. PMID: 23771290
-
A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan.Ann Clin Microbiol Antimicrob. 2006 Aug 26;5:18. doi: 10.1186/1476-0711-5-18. Ann Clin Microbiol Antimicrob. 2006. PMID: 16934158 Free PMC article. Clinical Trial.
-
Malaria: uncomplicated, caused by Plasmodium falciparum.Clin Evid. 2005 Jun;(13):988-1009. Clin Evid. 2005. PMID: 16135285 Review. No abstract available.
-
A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.Parasitol Res. 2014 May;113(5):1769-73. doi: 10.1007/s00436-014-3822-z. Epub 2014 Mar 8. Parasitol Res. 2014. PMID: 24609234 Review.
Cited by
-
Comparative Analysis of the Efficiency of Medicinal Plants for the Treatment and Prevention of COVID-19.Int J Biomater. 2022 Dec 10;2022:5943649. doi: 10.1155/2022/5943649. eCollection 2022. Int J Biomater. 2022. PMID: 36536929 Free PMC article. Review.
-
Antiviral activity of medicinal plant-derived products against SARS-CoV-2.Exp Biol Med (Maywood). 2022 Oct;247(20):1797-1809. doi: 10.1177/15353702221108915. Epub 2022 Jul 27. Exp Biol Med (Maywood). 2022. PMID: 35894129 Free PMC article. Review.
-
In vitro efficacy of Artemisia extracts against SARS-CoV-2.Virol J. 2021 Sep 8;18(1):182. doi: 10.1186/s12985-021-01651-8. Virol J. 2021. PMID: 34496903 Free PMC article.
-
Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.PLoS Negl Trop Dis. 2021 Jun 24;15(6):e0009511. doi: 10.1371/journal.pntd.0009511. eCollection 2021 Jun. PLoS Negl Trop Dis. 2021. PMID: 34166393 Free PMC article.
-
Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial.PLoS Negl Trop Dis. 2020 Sep 23;14(9):e0008619. doi: 10.1371/journal.pntd.0008619. eCollection 2020 Sep. PLoS Negl Trop Dis. 2020. PMID: 32966290 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous